Coronavirus-induced coagulopathy during the course of disease.

Marie Sophie FriedrichJan-Dirk StudtJulia BraunDonat R SpahnAlexander Kaserer

Published in: PloS one (2020)

We find coagulation alterations in COVID-19 patients indicating significant hypercoagulability. These alterations are visible despite antithrombotic treatment, and peak around week 3-4 of the disease.

Keyphrases

sars cov
atrial fibrillation
high glucose
randomized controlled trial
diabetic rats
oxidative stress
respiratory syndrome coronavirus
endothelial cells
study protocol
replacement therapy
smoking cessation
stress induced